Cargando…

Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents

Undifferentiated pleomorphic sarcoma (UPS) is an aggressive mesenchymal neoplasm with no specific line of differentiation. Eribulin, a novel synthetic microtubule inhibitor, has shown anticancer activity in several tumors, including soft tissue sarcomas (STS). We investigated the molecular biology o...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Vita, Alessandro, Recine, Federica, Mercatali, Laura, Miserocchi, Giacomo, Spadazzi, Chiara, Liverani, Chiara, Bongiovanni, Alberto, Pieri, Federica, Casadei, Roberto, Riva, Nada, Fausti, Valentina, Amadori, Dino, Ibrahim, Toni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751264/ https://www.ncbi.nlm.nih.gov/pubmed/29292724 http://dx.doi.org/10.3390/ijms18122662

Ejemplares similares

Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas
por: De Vita, Alessandro, et al.
Publicado: (2016)

Primary leiomyosarcoma of the bone: a case report and a review of the literature
por: Recine, Federica, et al.
Publicado: (2017)

Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
por: Recine, Federica, et al.
Publicado: (2017)

Myxofibrosarcoma primary cultures: molecular and pharmacological profile
por: De Vita, Alessandro, et al.
Publicado: (2017)

Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line
por: Miserocchi, Giacomo, et al.
Publicado: (2018)

Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma
por: De Vita, Alessandro, et al.
Publicado: (2016)

Management and potentialities of primary cancer cultures in preclinical and translational studies
por: Miserocchi, Giacomo, et al.
Publicado: (2017)

The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts
por: Mercatali, Laura, et al.
Publicado: (2016)

Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age
por: Bongiovanni, Alberto, et al.
Publicado: (2018)

mTOR inhibitor and bone-targeted drugs break the vicious cycle between clear-cell renal carcinoma and osteoclasts in an in vitro co-culture model
por: Spadazzi, Chiara, et al.
Publicado: (2019)

Unveiling the Genomic Basis of Chemosensitivity in Sarcomas of the Extremities: An Integrated Approach for an Unmet Clinical Need
por: Vanni, Silvia, et al.
Publicado: (2023)

Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition
por: Mercatali, Laura, et al.
Publicado: (2017)

A Rationale for the Activity of Bone Target Therapy and Tyrosine Kinase Inhibitor Combination in Giant Cell Tumor of Bone and Desmoplastic Fibroma: Translational Evidences
por: De Vita, Alessandro, et al.
Publicado: (2022)

Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by (18)fluorocholine PET/CT and its comparison with (68)gallium-DOTATOC PET/CT: Case report and review of the literature
por: Bongiovanni, Alberto, et al.
Publicado: (2017)

Grading of Neuroendocrine Carcinomas: Correlation of (68)Ga-PET/CT Scan with Tissue Biomarkers
por: Liverani, Chiara, et al.
Publicado: (2018)

Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectives
por: Vanni, Silvia, et al.
Publicado: (2022)

Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model
por: Liverani, Chiara, et al.
Publicado: (2016)

CORRECTION: Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model
por: Liverani, Chiara, et al.
Publicado: (2017)

Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy
por: Recine, Federica, et al.
Publicado: (2022)

The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient‐derived primary culture case series in tridimensional and zebrafish models
por: De Vita, Alessandro, et al.
Publicado: (2021)

Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model
por: Mercatali, Laura, et al.
Publicado: (2016)

Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
por: Bongiovanni, Alberto, et al.
Publicado: (2020)

BOne HEalth ManagEment in Patients with Early Breast Cancer: A Retrospective Italian Osteoncology Center “Real-Life” Experience (BOHEME Study)
por: Recine, Federica, et al.
Publicado: (2019)

The emerging role of cancer nanotechnology in the panorama of sarcoma
por: Mercatali, Laura, et al.
Publicado: (2022)

Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

Deciphering the Genomic Landscape and Pharmacological Profile of Uncommon Entities of Adult Rhabdomyosarcomas
por: De Vita, Alessandro, et al.
Publicado: (2021)

Lineage‐specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture
por: Liverani, Chiara, et al.
Publicado: (2021)

Lysyl oxidase engineered lipid nanovesicles for the treatment of triple negative breast cancer
por: De Vita, Alessandro, et al.
Publicado: (2021)

First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
por: Bongiovanni, Alberto, et al.
Publicado: (2015)

Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway
por: Amadori, Dino, et al.
Publicado: (2017)

Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio
por: Bongiovanni, Alberto, et al.
Publicado: (2021)

Undifferentiated pleomorphic sarcoma
por: Premkumar, Jeyanthi, et al.
Publicado: (2012)

Undifferentiated pleomorphic sarcoma
por: de Paiva, Ana Carolina Gonçalves, et al.
Publicado: (2018)

ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations
por: Debonis, Silvia Angela, et al.
Publicado: (2021)

Pleomorphic Undifferentiated Sarcoma of the Penis
por: Hayek, Omar Reda El, et al.
Publicado: (2008)

Undifferentiated Pleomorphic Sarcoma in Mandible
por: Kim, Chul-Hwan, et al.
Publicado: (2014)

Undifferentiated pleomorphic sarcoma of the mandible
por: Benites, Bernar Monteiro, et al.
Publicado: (2020)

Three-dimensional collagen-based scaffold model to study the microenvironment and drug-resistance mechanisms of oropharyngeal squamous cell carcinomas
por: Miserocchi, Giacomo, et al.
Publicado: (2021)

HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors
por: Liverani, Chiara, et al.
Publicado: (2023)

Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin
por: Fausti, Valentina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n8d9aotuq345rg0v27k764bu4j